Activin and Inhibin

LY2922470 is a potent, selective and orally available agonist of the G protein-coupled receptor 40 (GPR40) , with EC 50 s of 7 nM, 1 nM and 3 nM for human GPR40, mouse GPR40 and rat GPR40, respectively. LY2922470 reduces glucose levels along with

LY2922470 is a potent, selective and orally available agonist of the G protein-coupled receptor 40 (GPR40) , with EC 50 s of 7 nM, 1 nM and 3 nM for human GPR40, mouse GPR40 and rat GPR40, respectively. LY2922470 reduces glucose levels along with

LY2922470 is a potent, selective and orally available agonist of the G protein-coupled receptor 40 (GPR40) , with EC 50 s of 7 nM, 1 nM and 3 nM for human GPR40, mouse GPR40 and rat GPR40, respectively. LY2922470 reduces glucose levels along with

LY2922470 is a potent, selective and orally available agonist of the G protein-coupled receptor 40 (GPR40) , with EC 50 s of 7 nM, 1 nM and 3 nM for human GPR40, mouse GPR40 and rat GPR40, respectively. LY2922470 reduces glucose levels along with

LY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase ( GARFT ), with a K i of 6.5 nM, and has antitumor activity.In VitroLY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase (GARFT), with a K i of

LY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase ( GARFT ), with a K i of 6.5 nM, and has antitumor activity.In VitroLY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase (GARFT), with a K i of

LY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase ( GARFT ), with a K i of 6.5 nM, and has antitumor activity.In VitroLY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase (GARFT), with a K i of

LY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase ( GARFT ), with a K i of 6.5 nM, and has antitumor activity.In VitroLY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase (GARFT), with a K i of

LY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase ( GARFT ), with a K i of 6.5 nM, and has antitumor activity.In VitroLY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase (GARFT), with a K i of

LY3154207 is a potent, subtype selective, and orally available human dopamine D1 receptor positive allosteric modulator (PAM) with minimal allosteric agonist activity ( EC 50 =3 nM)In VitroIn HEK293 cells transiently expressing human, dog, rhesus

LY3154207 is a potent, subtype selective, and orally available human dopamine D1 receptor positive allosteric modulator (PAM) with minimal allosteric agonist activity ( EC 50 =3 nM)In VitroIn HEK293 cells transiently expressing human, dog, rhesus

LY3154207 is a potent, subtype selective, and orally available human dopamine D1 receptor positive allosteric modulator (PAM) with minimal allosteric agonist activity ( EC 50 =3 nM)In VitroIn HEK293 cells transiently expressing human, dog, rhesus